tiprankstipranks
Guggenheim ups Tarsus Pharmaceuticals price target, would buy on weakness
PremiumThe FlyGuggenheim ups Tarsus Pharmaceuticals price target, would buy on weakness
16d ago
Tarsus Pharmaceuticals: Strong Earnings and Growth Potential Make It a Buy
Premium
Ratings
Tarsus Pharmaceuticals: Strong Earnings and Growth Potential Make It a Buy
16d ago
Tarsus Pharmaceuticals: Undervalued Growth Potential and Acquisition Appeal Reinforce Buy Rating
Premium
Ratings
Tarsus Pharmaceuticals: Undervalued Growth Potential and Acquisition Appeal Reinforce Buy Rating
16d ago
Tarsus Pharmaceuticals reports Q4 EPS (60c), consensus (82c)
PremiumThe FlyTarsus Pharmaceuticals reports Q4 EPS (60c), consensus (82c)
17d ago
Strong Growth Prospects and Market Expansion Drive Buy Rating for Tarsus Pharmaceuticals
Premium
Ratings
Strong Growth Prospects and Market Expansion Drive Buy Rating for Tarsus Pharmaceuticals
1M ago
Tarsus Pharmaceuticals price target raised to $62 from $60 at Barclays
Premium
The Fly
Tarsus Pharmaceuticals price target raised to $62 from $60 at Barclays
2M ago
Tarsus Pharmaceuticals price target raised to $65 from $63 at Oppenheimer
PremiumThe FlyTarsus Pharmaceuticals price target raised to $65 from $63 at Oppenheimer
4M ago
Tarsus Pharmaceuticals Reports Strong Q3 2024 Performance
Premium
Company Announcements
Tarsus Pharmaceuticals Reports Strong Q3 2024 Performance
4M ago
Closing Bell Movers: Tetra Tech down 8% after Q4 results, guidance
Premium
The Fly
Closing Bell Movers: Tetra Tech down 8% after Q4 results, guidance
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100